Sexual dysfunction in patients with neuromyelitis optica spectrum disorder

被引:22
|
作者
Zhang, Ying [1 ]
Zhang, Qin [1 ]
Shi, Ziyan [1 ]
Chen, Hongxi [1 ]
Wang, Jiancheng [1 ]
Yan, Chao [1 ]
Du, Qin [1 ]
Qiu, Yuhan [1 ]
Zhao, Zhengyang [1 ]
Zhou, Hongyu [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Neurol, Guo Xuexiang 37, Chengdu 610041, Sichuan, Peoples R China
基金
国家重点研发计划;
关键词
Neuromyelitis optica spectrum disorder; Sexual dysfunction; Predictors; MULTIPLE-SCLEROSIS; CHINESE VERSION; FUNCTION INDEX; IMPAIRMENT; DISABILITY; ANXIETY; STATES; SCALE; TOOL;
D O I
10.1016/j.jneuroim.2019.577093
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Sexual dysfunction (SD) is a common but poorly understood symptom in patients with neuromyelitis optica spectrum disorder (NMOSD). The study was designed to compare SD between NMOSD patients and healthy controls (FICs), and to investigate factors that influenced SD in NMOSD patients. Methods: The study enrolled 102 sexually active NMOSD patients and 110 HCs. SD was investigated with the Female Sexual Function Inventory (FSFI), the abridged International Index of Erectile Function-5 (IIEF-5) and the Chinese Index of Premature Ejaculation-5 (CIPE-5). Disability, lower urinary tract dysfunction (LUTD), fatigue, depression and anxiety were also evaluated. Results: The prevalence of SD, including female sexual dysfunction (FSD), erectile dysfunction (ED), and premature ejaculation (PE), was significantly higher in NMOSD patients than in HCs (P < .01). The FSFI, IIEF-5 and CIPE-5 scores were all significantly lower in NMOSD patients than in HCs (P < .01). Correlation analysis showed that SD was strongly correlated with age, age at onset, disability, LUTD, fatigue, depression and anxiety (P < .05). Regression analysis further revealed that age at onset (OR = 1.057, P = .036), disability (OR = 1.591, P = .011), and depression (OR = 1.111, P = .041) were independent predictors of FSD in NMOSD patients. Conclusions: This study provided evidence that SD is a common problem in NMOSD patients and that age at onset, disability, and depression are independent predictors of FSD. More attention should be paid to SD in patients with NMOSD.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Prevalence, Demographic, and Clinical Factors Associated With Cognitive Dysfunction in Patients With Neuromyelitis Optica Spectrum Disorder
    Vlahovic, Luka
    McDonald, Jamie
    Hinman, Jessica
    Tomczak, Anna
    Lock, Christopher
    Palmer, Chella A.
    Cook, Lawrence J.
    Yeaman, Michael R.
    Burnett, Melinda K.
    Deutsch, Gayle K.
    Nelson, Lorene M.
    Han, May H.
    [J]. NEUROLOGY, 2024, 102 (01)
  • [42] Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder
    Kim, S. -H.
    Kwak, K.
    Hyun, J. -W.
    Jeong, I. H.
    Jo, H. -J.
    Joung, A.
    Kim, J. -H.
    Lee, S. H.
    Yun, S.
    Joo, J.
    Lee, J. -M.
    Kim, H. J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (07) : 1165 - 1173
  • [43] Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder
    Singh, Pratap
    Gao, Xiang
    Kleijn, Huub Jan
    Bellanti, Francesco
    Pelto, Ryan
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [44] Radiological characteristics of Neuromyelitis Optica Spectrum Disorder patients in Egypt
    Nasreldein, A.
    Farweez, H.
    Elfetoh, N. Abo
    Mahmoud, D.
    Badawy, E.
    Hassanein, S.
    Khedr, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 149 - 149
  • [45] MULTIDIMENSIONAL EVALUATION OF INEBILIZUMAB IN PATIENTS WITH NEUROMYELITIS OPTICA SPECTRUM DISORDER
    Fortunato, A.
    Antonini, D.
    Basile, M.
    Di Brino, E.
    Di Pippo, S.
    Falasca, G.
    Rumi, F.
    Cicchetti, A.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S348 - S348
  • [46] Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder
    Mealy, Maureen A.
    Cook, Lawrence J.
    Pache, Florence
    Velez, Diego L.
    Borisow, Nadja
    Becker, Daniel
    Arango, Jorge A. Jimenez
    Paul, Friedemann
    Levy, Michael
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 23 : 78 - 82
  • [47] Serum Creatine Kinase in Patients with Neuromyelitis Optica Spectrum Disorder
    Shouman, Kamal
    Prieto, Pilar G.
    Stino, Amro M.
    Lisak, Robert P.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2019, 330 : 87 - 89
  • [48] Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder
    Wang, Yuge
    Zhou, Yifan
    Sun, Xiaobo
    Lu, Tingting
    Wei, Lei
    Fang, Ling
    Chen, Chen
    Huang, Qiao
    Hu, Xueqiang
    Lu, Zhengqi
    Peng, Lisheng
    Qiu, Wei
    [J]. NEUROIMMUNOMODULATION, 2016, 23 (5-6) : 352 - 358
  • [49] Intractable cough as characteristic symptom of neuromyelitis optica and neuromyelitis optica spectrum disorder
    Fujita-Nakata, M.
    Tomioka, R.
    Tanaka, K.
    Nakanishi, M.
    Nagayama, S.
    Takahashi, R.
    Machiya, T.
    Hamada, T.
    Matsui, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (04) : 576 - 577
  • [50] Immunosuppressive therapy in elderly patients with neuromyelitis optica spectrum disorder
    Kim, Su-Hyun
    Kim, Ki Hoon
    Chung, Yeon Hak
    Min, Ju-Hong
    Han, Hee Jo
    Kim, Seung Woo
    Shin, Ha Young
    Lee, Eun-Jae
    Lim, Young-Min
    Kwon, Young Nam
    Kim, Sung Min
    Hyun, Jae-Won
    Kim, Ho Jin
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 146 - 146